Answers are grounded in this paper and cite their sources.
and CL. However, when the data were unpaired and clustered for comparative analysis, only 5 out of the 12 analyzed nanoformulations maintained a higher relative curcumin concentration in plasma over time compared to free curcumin. Quantitative analysis of the mean plasma concentration of free curcumin versus nanoformulated curcumin did not reveal an overall marked improvement in curcumin PK. No correlation was found between PK and PD, suggesting that augmentation of the systemic presence of curcumin does not necessarily lead to greater therapeutic efficacy.
No takes yet. Share an insight, caveat, or question.
Bagheri et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: